ClinicalIn DepthNews

April MIMS update

counterfeit medicine
Pharmacist or expert on pharmaceutical inspection identifies pills. Testing, verification and determining pharmaceutical counterfeiting or fakes of medicines and medicinal substance quality concept
We look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Fezolinetant (Veoza) is a nonhormonal selective NK3 receptor antagonist that blocks neurokinin B (NKB) binding on kisspeptin/neurokinin B/dynorphin (KNDy) neurons to modulate neuronal activity in the thermoregulatory centre. The thermoregulatory centre in the hypothalamus is

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Locum rates forecast to flatten
Next Are pharmacists ready for a rebound in Chinese customers?

Related Posts